Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocol.

Liang KangZiwei ZengShuangling LuoHong ZhangQuan WangMingyang RenMiao WuWeidong TongQing XuYi XiaoAiwen WuYuan-Guang ChenBo FengZhanlong ShenLiang HuangXingwei ZhangMinhua ZhengJian-Ping Wang

Published in: Gastroenterology report (2020)

The TaLaR trial is expected to clarify whether taTME can achieve comparable oncological outcomes, as well as improve specimen quality and recovery conditions in rectal-cancer patients compared with lapTME.

Keyphrases

phase iii
rectal cancer
clinical trial
double blind
open label
locally advanced
placebo controlled
phase ii
randomized controlled trial
robot assisted
prostate cancer
metabolic syndrome
squamous cell carcinoma
skeletal muscle
insulin resistance
quality improvement
minimally invasive
radical prostatectomy